Drug profile · INN
flutemetamol f-18
VIZAMYL
flutemetamol f-18 (VIZAMYL) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — flutemetamol f-18
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 6
- Data quality
- 0.84
Quick answer
flutemetamol f-18 (VIZAMYL) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN flutemetamol f-18
Brand VIZAMYL
Mechanism Diagnostic agent
Route INTRAVENOUS
Formulation INJECTABLE
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is flutemetamol f-18?
flutemetamol f-18 (VIZAMYL) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for flutemetamol f-18?
VIZAMYL is a marketed brand name for flutemetamol f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flutemetamol f-18?
flutemetamol f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.